Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...

A review in Brain Medicine unveils the potential of targeted alpha particle therapy (TAT) as an innovative and exciting ...

Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.

Alpha Teknova shares rose Wednesday morning in premarket trading after the company said that it will partner with Pluristyx, to bring to market a product line for therapies that use donor cells to ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body.

Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

Alpha Teknova (TKNO) and Pluristyx announced that the companies are collaborating to produce and commercialize Pluristyx’s PluriFreeze product ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers from Japan recently developed a new radioactive drug that ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...